홈 › 전이성 암 › 오하이오 › Cincinnati
OH Cincinnati의 전이성 암 임상 시험
전이성 암 관련 연구 20개가 Cincinnati 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
피험자 모집 중2상
- Good Samaritan Hospital - Cincinnati, Cincinnati
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
피험자 모집 중1상
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15마일 거리
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중3상
- Oncology Hematology Care - Eastgate, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15마일 거리
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
피험자 모집 중3상
- Oncology Hematology Care Clinical Trials, Cincinnati
- Oncology Hematology Care Clinical Trials, Cincinnati
- Oncology Hematology Care Clinical Trials, Cincinnati
- 외 1개
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
피험자 모집 중3상
- Research Site, Cincinnati
- Research Site, Cincinnati
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
피험자 모집 중3상
- University of Cincinnati Medical Center, Cincinnati
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8마일 거리
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
피험자 모집 중3상
- University of Cincinnati Medical Center, Cincinnati
- Oncology Hematology Care Inc, Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
피험자 모집 중3상
- Research Site, Edgewood · 8마일 거리
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- USO - Oncology Hematology Care, Cincinnati
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
피험자 모집 중2상
- St. Elizabeth Healthcare, Edgewood · 8마일 거리
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
피험자 모집 중1상
- University of Cincinnati Medical Center (UCMC), Cincinnati
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Oncology Hematology Care Primary, Cincinnati
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
피험자 모집 중3상
- Research Site, Cincinnati
A Study of PYX-201 in Advanced Solid Tumors
피험자 모집 중1상
- University of Cincinnati Medical Center, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- The Christ Hospital, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- Christ Hospital Cancer Center, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
피험자 모집 중2상
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
피험자 모집 중1상
- The Christ Hospital Cancer Center, Cincinnati
다른 도시의 전이성 암 시험
- Houston, TX연구 104개
- New York City, NY연구 93개
- Nashville, TN연구 70개
- Boston, MA연구 63개
- Los Angeles, CA연구 57개
- St. Louis, MO연구 54개
- Arlington, VA연구 53개
- Philadelphia, PA연구 46개
- Chicago, IL연구 45개
- San Antonio, TX연구 44개
- Washington, DC연구 43개
- Dallas, TX연구 42개
Cincinnati의 다른 연구
- 비소세포폐암연구 35개
- 암 (전체)연구 27개
- 유방암연구 25개
- 심부전연구 24개
- 대장직장암연구 21개
- 급성 골수성 백혈병연구 20개
- 난소암연구 19개
- 폐암연구 19개
- 비만연구 19개
- 전립선암연구 18개
- 다발성 골수종연구 17개
- 흑색종연구 17개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.